Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 45 min ago
Peer-reviewedCC BY 4.0PLOS Global Public Health

Quantifying excess TB prevalence among people living with HIV on ART in the universal ART era: Evidence from a TB prevalence survey in Zambia and South Africa

  • Thomas Gachie1
  • Eveline Klinkenberg2
  • Kwame Shanaube3
  • Linda Mureithi4
  • Peter J. Dodd5
  • Maria Ruperez
  • Ab Schaap
  • Richard Hayes
  • Helen Ayles
  • Jonathan Bartlett
  • Sian Floyd
5 affiliations
  1. 1London School of Hygiene & Tropical Medicine (LSHTM), London, United Kingdom
  2. 2Zambart, Lusaka, Zambia
  3. 3Sheffield Centre for Health and Related Research, School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom
  4. 4ConnectTB, the Hague, The Netherlands
  5. 5Health Systems Trust, Cape Town, South Africa
Read full textPDFDOICite

Abstract

Despite widespread antiretroviral therapy (ART) scale-up, tuberculosis (TB) remains a leading cause of morbidity and mortality among people living with HIV (PLHIV). While ART reduces TB incidence among PLHIV, its effect on TB prevalence remains less clear. We estimated the difference in TB prevalence between PLHIV on ART and their counterfactual HIV-negative state, quantifying their proportionate contribution to overall TB prevalence in high-HIV settings across Southern Africa. Using data from the 2019–2021 TREATS TB prevalence survey, a cross-sectional survey of adults aged ≥15 years in 21 communities in Zambia and South Africa (SA) (Western Cape province), we applied Rubin’s “potential outcomes” framework and inverse probability of treatment weighting, with propensity scores estimated using logistic regression to control for measured confounding. We estimated the average treatment effect on the treated (ATT) as the TB prevalence difference (PD) among PLHIV on ART compared to a counterfactual scenario where the same individuals were HIV-negative. Among 43,617 analysed, 6,612 (15.2%) were PLHIV on ART and 37,005 (84.8%) tested HIV-negative. After adjusting for confounding, PLHIV on ART had higher TB prevalence than the counterfactual HIV-negative scenario (ATT: PD = 0.53%; 95% confidence interval [CI]: 0.19, 0.87). There was statistical evidence of an effect in the Zambian communities (ATT: PD = 0.49%; 95% CI: 0.14, 0.85), but the evidence was weaker in SA communities (ATT: PD = 0.56%; 95% CI: -0.15, 1.26). At the population level, PLHIV on ART contributed an absolute excess of 0.08% to overall TB prevalence, representing a 9.3% proportionate increase, which was larger in Zambian (14.8%) than in SA (5.6%) communities due to background TB prevalence differences. PLHIV on ART remain at elevated risk of prevalent TB, contributing considerably to overall TB prevalence, underscoring the need for continued, targeted TB prevention, screening, and treatment strategies for all PLHIV in settings with a high burden of both TB and HIV. Trial registration ClinicalTrials.gov NCT03739736

Related

  1. Prevalence of NASH/NAFLD in people with obesity who are currently classified as metabolically healthy
    Sébastien Frey, Stéphanie Patouraux, Tarek Debs +3
    Surgery for Obesity and Related DiseasesPeer-reviewedLicence not statedFull text30 citedGeneral biologySurgery & anaesthesiaHAL
  2. Prevalence of common mental health disorders and associated factors among adolescents and young people living with HIV in Lusaka, Zambia
    Kwame Shanaube, Suwilanji Simwanza, Buumba Tapisha +13
    PLOS Mental HealthPeer-reviewedCC BY 4.0Full textImmunologyMicrobiologyPLOS
  3. Hepatitis C RNA Prevalence before and during Broad Access to Direct-Acting Antivirals in People with HIV across Six Countries
    Ashleigh C. Stewart, Constantin T. Yiannoutsos, Damian Pavlyshyn +21
    JHEP Reports Innovation in HepatologyPeer-reviewedCC BY-NC-NDFull textGeneral biologyEpidemiology & public healthHAL
  4. Physiological signatures but no evidence for universal genomic predictors of extreme drought responses in European beech
    C. Li, L. C. de Witte, E. A. Czyz +6
    bioRxivPreprintCC BYFull textEcologybioRxiv
  5. Social vision expands into auditory cortices of people born deaf: evidence from naturalistic film and encoding models
    M. Zimmermann, M. Szwed, L. Isik +1
    bioRxivPreprintCC BYFull textNeurosciencebioRxiv

Cite

BibTeXRIS
BibTeX
@article{gachie2026quantifying,
  title = {{Quantifying excess TB prevalence among people living with HIV on ART in the universal ART era: Evidence from a TB prevalence survey in Zambia and South Africa}},
  author = {Thomas Gachie and Eveline Klinkenberg and Kwame Shanaube and Linda Mureithi and Peter J. Dodd and Maria Ruperez and Ab Schaap and Richard Hayes and Helen Ayles and Jonathan Bartlett and Sian Floyd},
  journal = {PLOS Global Public Health},
  year = {2026},
  month = sep,
  doi = {10.1371/journal.pgph.0006833},
  url = {https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0006833},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Quantifying excess TB prevalence among people living with HIV on ART in the universal ART era: Evidence from a TB prevalence survey in Zambia and South Africa
AU  - Thomas Gachie
AU  - Eveline Klinkenberg
AU  - Kwame Shanaube
AU  - Linda Mureithi
AU  - Peter J. Dodd
AU  - Maria Ruperez
AU  - Ab Schaap
AU  - Richard Hayes
AU  - Helen Ayles
AU  - Jonathan Bartlett
AU  - Sian Floyd
PY  - 2026
DA  - 2026/09/21
JO  - PLOS Global Public Health
DO  - 10.1371/journal.pgph.0006833
UR  - https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0006833
AB  - Despite widespread antiretroviral therapy (ART) scale-up, tuberculosis (TB) remains a leading cause of morbidity and mortality among people living with HIV (PLHIV). While ART reduces TB incidence among PLHIV, its effect on TB prevalence remains less clear. We estimated the difference in TB prevalence between PLHIV on ART and their counterfactual HIV-negative state, quantifying their proportionate contribution to overall TB prevalence in high-HIV settings across Southern Africa. Using data from the 2019–2021 TREATS TB prevalence survey, a cross-sectional survey of adults aged ≥15 years in 21 communities in Zambia and South Africa (SA) (Western Cape province), we applied Rubin’s “potential outcomes” framework and inverse probability of treatment weighting, with propensity scores estimated using logistic regression to control for measured confounding. We estimated the average treatment effect on the treated (ATT) as the TB prevalence difference (PD) among PLHIV on ART compared to a counterfactual scenario where the same individuals were HIV-negative. Among 43,617 analysed, 6,612 (15.2%) were PLHIV on ART and 37,005 (84.8%) tested HIV-negative. After adjusting for confounding, PLHIV on ART had higher TB prevalence than the counterfactual HIV-negative scenario (ATT: PD = 0.53%; 95% confidence interval [CI]: 0.19, 0.87). There was statistical evidence of an effect in the Zambian communities (ATT: PD = 0.49%; 95% CI: 0.14, 0.85), but the evidence was weaker in SA communities (ATT: PD = 0.56%; 95% CI: -0.15, 1.26). At the population level, PLHIV on ART contributed an absolute excess of 0.08% to overall TB prevalence, representing a 9.3% proportionate increase, which was larger in Zambian (14.8%) than in SA (5.6%) communities due to background TB prevalence differences. PLHIV on ART remain at elevated risk of prevalent TB, contributing considerably to overall TB prevalence, underscoring the need for continued, targeted TB prevention, screening, and treatment strategies for all PLHIV in settings with a high burden of both TB and HIV. Trial registration ClinicalTrials.gov NCT03739736
SN  - 2767-3375
ER  -